Shulamit Levenberg

Shulamit Levenberg, of the Technion Faculty of Biomedical Engineering Department, is the director of the Technion Center for 3D Bioprinting and the Rina & Avner Schneur Center for Diabetes Research.

Shulamit Levenberg is the director of both the Technion Center for 3D Bioprinting and the Rina & Avner Schneur Center for Diabetes Research, and holds the Stanley and Sylvia Shirvan Chair in Cancer and Life Sciences in the Faculty of Biomedical Engineering.

Prof. Levenberg conducts interdisciplinary research on stem cells and tissue engineering. Her research shows that it is possible to create complex tissues including blood vessels in a laboratory and that these engineered tissue-constructs can integrate with the host when implanted. She is also developing micro bioreactors and nanoliter droplet devices for stem cell growth and manipulations.

Prof. Levenberg received the Krill Prize for Excellence in Scientific Research, awarded by the Wolf Foundation, and was named by Scientific American as a “Research Leader” in tissue engineering, for her seminal work on vascularization of engineered tissues. She also received the France-Israel Foundation Prize, the Italian Excellence. for Israel Prize, the Teva Founders Prize and Research Grant and the Juludan Research Prize. In 2018, she received the Rappaport Prize for Excellence in Biomedical Sciences and in 2019 received the Michael Bruno Memorial Award.

She is founder and CSO of two start-up companies, including Aleph Farms, which is revolutionizing the food industry by producing real meat from cow cells without damaging the environment. She is a member of the Israel National Council for Bioethics and is actively involved in training young scientists.